The cytoprotection in dialysis patient by applying creatine compound

The cytoprotection in dialysis patient by applying creatine compound

  • CN 102,573,828 B
  • Filed: 07/21/2010
  • Issued: 02/23/2018
  • Est. Priority Date: 07/24/2009
  • Status: Active Grant
First Claim
Patent Images

1. for the dialysis solution of haemodialysis or peritoneal dialysis, the solution has the reason within the scope of 250~550mosm/LBy the pH value within the scope of osmolarity and 4.9~8.0, the solution includes creatine compound and one or more electrolyte,The dialysis solution also includes 100~180mM Na+, the wherein concentration of creatine compound is not more than 50mM.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×